61 results
8-K
EX-10.3
DMKPQ
DMK Pharmaceuticals Corp
19 Oct 23
Entry into a Material Definitive Agreement
5:07pm
address and telephone number, date of birth, social security number or other identification number, salary, nationality, job title, any shares of stock
8-K
EX-10.4
DMKPQ
DMK Pharmaceuticals Corp
19 Oct 23
Entry into a Material Definitive Agreement
5:07pm
Optionee, including, but not limited to, Optionee’s name, home address and telephone number, date of birth, social security number or other
DEFC14A
DMKPQ
DMK Pharmaceuticals Corp
12 Oct 23
Proxy in contested solicitation
4:22pm
, as applicable, employing the Participant an amount sufficient to satisfy applicable U.S. federal, state, local, and international tax or any other tax or social
PREC14A
DMKPQ
DMK Pharmaceuticals Corp
2 Oct 23
Preliminary proxy with contested solicitation
4:49pm
, and international tax or any other tax or social insurance liability (the “Tax-Related Items”) legally due from the Participant prior to the delivery
424B4
4g6ntl79pptfqip
3 Aug 23
Prospectus supplement with pricing info
4:55pm
8-K
EX-10.1
qgj9 lhkr
24 Jul 23
Entry into a Material Definitive Agreement
4:20pm
8-K
EX-10.2
34cfsyp
26 May 23
Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals
4:25pm
DEFM14A
1x6sh1ttsijqs7
13 Apr 23
Proxy related to merger
4:52pm
DEFA14A
alb2n
21 Jul 22
Additional proxy soliciting materials
4:23pm